Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:INNT

Innovate Biopharmaceuticals (INNT) Stock Price, News & Analysis

Innovate Biopharmaceuticals logo

About Innovate Biopharmaceuticals Stock (NASDAQ:INNT)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.56
$1.42
52-Week Range
N/A
Volume
18 shs
Average Volume
525,982 shs
Market Capitalization
$8 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive INNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Innovate Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

INNT Stock News Headlines

Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.
See More Headlines

INNT Stock Analysis - Frequently Asked Questions

Innovate Biopharmaceuticals Inc (NASDAQ:INNT) released its quarterly earnings results on Monday, March, 18th. The company reported ($0.11) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.11).

Based on aggregate information from My MarketBeat watchlists, some other companies that Innovate Biopharmaceuticals investors own include 9 Meters Biopharma (NMTR), NIO (NIO), Corbus Pharmaceuticals (CRBP), Energy Transfer (ET), Iterum Therapeutics (ITRM), Meta Platforms (META) and Micron Technology (MU).

Company Calendar

Last Earnings
3/18/2019
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:INNT
CIK
1551986
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$27.05 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-234.42%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.35
Quick Ratio
0.35

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.27) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
41,325,000
Free Float
N/A
Market Cap
$8 thousand
Optionable
Not Optionable
Beta
-0.39
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:INNT) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners